Stifel initiated coverage on Jasper Therapeutics with a new price target
$JSPR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Stifel initiated coverage of Jasper Therapeutics with a rating of Buy and set a new price target of $86.00